Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endocrine orbitopathy--diagnosis].

A Langmann1, S Lindner

  • 1Universitäts-Augenklinik, Karl Franzens Universität, Graz. andrea.langmann@kfunigraz.ac.at

Acta Medica Austriaca
|October 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[18F]fluorodeprenyl-D2 PET can detect and monitor astrogliosis in anti-LGI1-IgG autoimmune encephalitis.

European journal of nuclear medicine and molecular imaging·2025
Same author

Fibrillar amyloidosis and synaptic vesicle protein expression progress jointly in the cortex of a mouse model with β-amyloid pathology.

NeuroImage·2025
Same author

Coupling of single nanodiamonds hosting SiV color centers to plasmonic double bowtie microantennas.

Nanotechnology·2025
Same author

From the bench to practice - Field integration of community-based services for older citizens with different levels of functional limitation across European Regions.

Translational medicine @ UniSa·2021
Same author

In Phantom Validation of Time-Domain Near-Infrared Optical Tomography Pioneer for Imaging Brain Hypoxia and Hemorrhage.

Advances in experimental medicine and biology·2021
Same author

Probe Design Optimization for Time-Domain NIROT "Pioneer" System for Imaging the Oxygenation of the Preterm Brain.

Advances in experimental medicine and biology·2021
Same journal

[Gestational diabetes mellitus].

Acta medica Austriaca·2005
Same journal

[Diagnosis, therapy and follow-up of diabetic eye diseases].

Acta medica Austriaca·2005
Same journal

[Diabetic nephropathy].

Acta medica Austriaca·2005
Same journal

[The diabetic foot].

Acta medica Austriaca·2005
Same journal

[Diabetic neuropathy].

Acta medica Austriaca·2005
Same journal

[Inhibition of platelet aggregation].

Acta medica Austriaca·2005
See all related articles

The NOSPECS scheme offers a standardized method for classifying ocular changes in Graves' disease. This approach aids in consistent evaluation of endocrine orbitopathy, improving patient care.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Medical Classification Systems

Context:

  • Endocrine orbitopathy, commonly associated with Graves' disease, presents with diverse ocular and periocular manifestations.
  • Existing classification systems for endocrine orbitopathy have undergone various modifications.
  • The NOSPECS (Euthyroid, Ophthalmopathy, Skin/extremities, Proptosis, Diplopia, Strabismus) scheme is a widely recognized modification.

Purpose:

  • To discuss the application and utility of the NOSPECS scheme.
  • To evaluate the effectiveness of the NOSPECS scheme in classifying ocular and periocular changes in Graves' disease.
  • To highlight the benefits of a standardized classification system in managing endocrine orbitopathy.

Summary:

  • The study reviews modifications to the traditional Werner classification for endocrine orbitopathy.

Related Experiment Videos

  • It specifically examines the implementation of the NOSPECS scheme.
  • The focus is on how NOSPECS categorizes the ocular and periocular alterations observed in patients with Graves' disease.

    • Impact:

    • Standardized classification aids in objective assessment and monitoring of disease progression.
    • Consistent application of NOSPECS can improve communication among healthcare providers.
    • Facilitates comparative studies and research on treatment efficacy for Graves' disease-related eye conditions.